LUMO - LUMOS PHARMA, INC.

QQQ $ 461.27 $ -12.41 (-2.62 %)

DIA $ 410.26 $ -5.95 (-1.43 %)

SPY $ 551.70 $ -9.13 (-1.63 %)

TLT $ 97.57 $ 1.08 (1.12 %)

GLD $ 230.29 $ -1.00 (-0.43 %)

Previous Close

$ 3.9

Open

$ 3.86

Bid

$ 3.75 x 250

Ask

-- x --

Day's Range

$ 3.82 - $ 3.96

52 Week Range

$ 1.37 - $ 4.55

Volume

115,912

Average Volume

Market Cap

31.68M

Beta (5Y Monthly)

$ -3.28

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-02-2024	06-30-2024	10-Q
2	05-15-2024	03-31-2024	10-Q
3	03-07-2024	12-31-2023	10-K
4	11-07-2023	09-30-2023	10-Q
5	08-10-2023	06-30-2023	10-Q
6	05-05-2023	03-31-2023	10-Q
7	03-07-2023	12-31-2022	10-K
8	11-14-2022	09-30-2022	10-Q
9	08-10-2022	06-30-2022	10-Q
10	05-11-2022	03-31-2022	10-Q
11	03-11-2022	12-31-2021	10-K
12	11-05-2021	09-30-2021	10-Q
13	08-06-2021	06-30-2021	10-Q
14	05-06-2021	03-31-2021	10-Q
15	03-09-2021	12-31-2020	10-K
16	11-12-2020	09-30-2020	10-Q
17	08-14-2020	06-30-2020	10-Q
18	06-02-2020	03-31-2020	10-Q
19	03-03-2020	12-31-2019	10-K
20	11-06-2019	09-30-2019	10-Q
21	08-08-2019	06-30-2019	10-Q
22	05-08-2019	03-31-2019	10-Q
23	03-05-2019	12-31-2018	10-K
24	11-02-2018	09-30-2018	10-Q
25	08-06-2018	06-30-2018	10-Q
26	05-09-2018	03-31-2018	10-Q
27	03-05-2018	12-31-2017	10-K
28	11-03-2017	09-30-2017	10-Q
29	08-03-2017	06-30-2017	10-Q
30	05-05-2017	03-31-2017	10-Q
31	03-06-2017	12-31-2016	10-K
32	11-08-2016	09-30-2016	10-Q
33	08-05-2016	06-30-2016	10-Q
34	04-29-2016	03-31-2016	10-Q
35	02-29-2016	12-31-2015	10-K
36	11-06-2015	09-30-2015	10-Q
37	08-06-2015	06-30-2015	10-Q
38	05-11-2015	03-31-2015	10-Q
39	03-16-2015	12-31-2014	10-K
40	11-10-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Oppenheimer Maintains Outperform on Lumos ...
08/02/2024 15:50:21

Oppenheimer analyst Leland Gershell maintains Lumos Pharma (NASDAQ:LUMO) with a Outperform and lowers the price target from ...

Lumos Pharma Q2 2024 GAAP EPS $(0.93) Beat...
08/01/2024 20:40:00

Lumos Pharma (NASDAQ:LUMO) reported quarterly losses of $(0.93) per share which beat the analyst consensus estimate of $(1.24) ...

Lumos Pharma Reports New Analyses Of Phase...
06/04/2024 13:01:01

Lumos Pharma Q1 2024 GAAP EPS $(1.29) Miss...
05/14/2024 20:53:18

Lumos Pharma (NASDAQ:LUMO) reported quarterly losses of $(1.29) per share which missed the analyst consensus estimate of $(1.18...

Lumos Pharma Announces Positive End-of-Pha...
05/14/2024 20:16:57

Lumos Pharma Announces Abstracts Reviewing...
04/18/2024 20:08:11

HC Wainwright & Co. Reiterates Buy on Lumo...
03/20/2024 16:29:58

HC Wainwright & Co. analyst Edward White reiterates Lumos Pharma (NASDAQ:LUMO) with a Buy and maintains $28 price target.

Lumos Pharma Announces USPTO Has Granted P...
03/20/2024 12:06:30

Oppenheimer Maintains Outperform on Lumos ...
03/08/2024 14:04:36

Oppenheimer analyst Leland Gershell maintains Lumos Pharma (NASDAQ:LUMO) with a Outperform and maintains $16 price target.

HC Wainwright & Co. Reiterates Buy on Lumo...
03/08/2024 11:52:01

HC Wainwright & Co. analyst Edward White reiterates Lumos Pharma (NASDAQ:LUMO) with a Buy and maintains $28 price target.

Lumos Pharma: Q4 Earnings Insights
03/07/2024 21:10:07

Lumos Pharma Q4 2023 GAAP EPS $(1.170) Mis...
03/07/2024 21:09:35

Lumos Pharma (NASDAQ:LUMO) reported quarterly losses of $(1.170) per share which missed the analyst consensus estimate of $(1.1...

Earnings Scheduled For March 7, 2024
03/07/2024 09:49:44

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...

Earnings Preview: Lumos Pharma
03/06/2024 18:01:39

Oppenheimer Maintains Outperform on Lumos ...
12/11/2023 15:21:08

Oppenheimer analyst Leland Gershell maintains Lumos Pharma (NASDAQ:LUMO) with a Outperform and lowers the price target from ...

HC Wainwright & Co. Reiterates Buy on Lumo...
12/07/2023 11:43:35

HC Wainwright & Co. analyst Edward White reiterates Lumos Pharma (NASDAQ:LUMO) with a Buy and maintains $28 price target.

Lumos Pharma To Host Virtual Key Opinion L...
11/21/2023 21:29:37

Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for moderate Pediatric Gr...

why-toast-shares-are-trading-lower-by-around-17-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why Toast Shares Are Trading Lower By Arou...
11/08/2023 18:41:58

Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares climbed 96% to $0.2921 after falling over 7% on Tuesday.

why-is-biomarin--bridgebio-pharma-rival-lumos-pharma-stock-trading-higher-today

Why Is Biomarin & BridgeBio Pharma Rival L...
11/08/2023 18:20:41

Lumos Pharma Inc (NASDAQ: LUMO) announced that topline results from its Phase 2 OraGrowtH210 dose-finding trial and its Phase 2...

Roblox, Under Armour, GoPro, Nuvei And Oth...
11/08/2023 16:02:42

U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 20 points on Wednesday. Here are some big stocks reco...